Sky Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
1,448
-25
-2% -$25.5K 0.27% 72
2026
Q1
$1.36M Buy
1,473
+20
+1% +$20.3K 0.23% 79
2025
Q4
$1.56M Sell
1,453
-20
-1% -$19.1K 0.26% 77
2025
Q3
$1.12M Hold
1,473
0.19% 83
2025
Q2
$1.15M Sell
1,473
-10
-0.7% -$7.77K 0.2% 83
2025
Q1
$1.22M Buy
1,483
+5
+0.3% +$4.16K 0.23% 83
2024
Q4
$1.14M Sell
1,478
-25
-2% -$20.7K 0.21% 83
2024
Q3
$1.33M Hold
1,503
0.24% 80
2024
Q2
$1.36M Sell
1,503
-36
-2% -$28.8K 0.26% 77
2024
Q1
$1.2M Hold
1,539
0.23% 77
2023
Q4
$897K Hold
1,539
0.19% 82
2023
Q3
$826K Hold
1,539
0.19% 82
2023
Q2
$722K Sell
1,539
-15
-1% -$6.29K 0.16% 91
2023
Q1
$534K Sell
1,554
-25
-2% -$8.43K 0.12% 91
2022
Q4
$578K Sell
1,579
-15
-0.9% -$5.32K 0.14% 91
2022
Q3
$515K Hold
1,594
0.13% 92
2022
Q2
$517K Buy
1,594
+501
+46% +$150K 0.12% 92
2022
Q1
$313K Hold
1,093
0.07% 112
2021
Q4
$302K Hold
1,093
0.06% 116
2021
Q3
$253K Sell
1,093
-12
-1% -$2.96K 0.06% 119
2021
Q2
$254K Hold
1,105
0.06% 116
2021
Q1
$206K Sell
1,105
-115
-9% -$22.5K 0.05% 118
2020
Q4
$206K Buy
+1,220
New +$182K 0.05% 116

Other funds holding LLY

Sky Investment Group's LLY Position: Q2 2026 in Review

Sky Investment Group reduced its Eli Lilly (LLY) stake by 1.7% in Q2 2026, selling an estimated $25.5K and leaving 1,448 shares worth $1.74M. The position accounts for 0.27% of the portfolio, ranked #72.

Sky Investment Group first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sky Investment Group held 1,448 shares of Eli Lilly worth $1.74M as of Q2 2026.
  • Sky Investment Group sold 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.27% of Sky Investment Group's portfolio in Q2 2026, its #72 holding.
  • Sky Investment Group first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sky Investment Group's 13F filing for Q2 2026, filed 20 Jul 2026.